These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3542534)

  • 1. Pharmacokinetics of primaquine in patients with P. vivax malaria.
    Bhatia SC; Saraph YS; Revankar SN; Doshi KJ; Bharucha ED; Desai ND; Vaidya AB; Subrahmanyam D; Gupta KC; Satoskar RS
    Eur J Clin Pharmacol; 1986; 31(2):205-10. PubMed ID: 3542534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
    Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.
    Li Q; O'Neil M; Xie L; Caridha D; Zeng Q; Zhang J; Pybus B; Hickman M; Melendez V
    Malar J; 2014 Apr; 13():141. PubMed ID: 24731238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
    Mihaly GW; Ward SA; Edwards G; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1984 Apr; 17(4):441-6. PubMed ID: 6721990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective pharmacokinetics of primaquine in healthy human volunteers.
    Tekwani BL; Avula B; Sahu R; Chaurasiya ND; Khan SI; Jain S; Fasinu PS; Herath HM; Stanford D; Nanayakkara NP; McChesney JD; Yates TW; ElSohly MA; Khan IA; Walker LA
    Drug Metab Dispos; 2015 Apr; 43(4):571-7. PubMed ID: 25637634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.
    Bertol CD; Oliveira PR; Kuminek G; Rauber GS; Stulzer HK; Silva MA
    Ann Trop Med Parasitol; 2011 Oct; 105(7):475-84. PubMed ID: 22185941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
    Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
    Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
    Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
    Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions among primaquine, malaria infection and other antimalarials in Thai subjects.
    Edwards G; McGrath CS; Ward SA; Supanaranond W; Pukrittayakamee S; Davis TM; White NJ
    Br J Clin Pharmacol; 1993 Feb; 35(2):193-8. PubMed ID: 8443039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
    Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
    Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects.
    Ward SA; Mihaly GW; Edwards G; Looareesuwan S; Phillips RE; Chanthavanich P; Warrell DA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1985 Jun; 19(6):751-5. PubMed ID: 4027118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
    Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
    Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of sex effect on the pharmacokinetics of primaquine.
    Elmes NJ; Bennett SM; Abdalla H; Carthew TL; Edstein MD
    Am J Trop Med Hyg; 2006 Jun; 74(6):951-2. PubMed ID: 16760502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
    St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
    Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
    Pinilla YT; C P Lopes S; S Sampaio V; Andrade FS; Melo GC; Orfanó AS; Secundino NFC; Guerra MGVB; Lacerda MVG; Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Stoops CA; Baldeviano GC; Tarning J; Vasquez GM; Pimenta PFP; Monteiro WM
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006221. PubMed ID: 29444080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.